...
首页> 外文期刊>Journal of Medicine, Physiology and Biophysics >OUTCOME OF INTRAVENOUS ACETAMINOPHEN IN PAIN RELIEF AMONG UNDERGOING ABDOMINAL HYSTERECTOMY
【24h】

OUTCOME OF INTRAVENOUS ACETAMINOPHEN IN PAIN RELIEF AMONG UNDERGOING ABDOMINAL HYSTERECTOMY

机译:接受腹部子宫切除术中疼痛缓解中静脉乙酰乙酰乙酰乙酰乙酰乙酰乙酰氨基酚的结果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective; To determine the efficacy of intravenous acetaminophen for postoperative pain after abdominal hysterectomy. Material and Methods; A total of 114 women undergoing abdominal hysterectomy were taken in this study. The study was conducted from June 2018 to May 2019 at department of Anesthesiology, Nishtar Hospital, Multan. Results; Our study comprised of 114 ladies undergoing abdominal hysterectomy, mean age of the study cases was 54.13 ± 6.89 years (with minimum age of the patients was 39 years while maximum age was 68 years). Majority of our study cases i.e. 92 (80.7 %) had parity more than 3 and American Society of Anesthesiology (ASA) score level 1 in 93 (81.6%). Sixty one (53.1%) belonged to rural areas, while mean duration of surgery was 72.80 ± 11.32 minutes. Mean BMI level in our study cases was noted to be 23.98 ±4.17 Kg/m 2 and obesity was present in 34 (29.8%) of our study cases and Efficacy in terms of pain reduction was 73.7%. Conclusion; Our study results support the use of intravenous acetaminophen (IVA) for pain management in patients undergoing abdominal hysterectomy. Intravenous acetaminophen is safe, reliable and effective for the pain management in postoperative abdominal hysterectomy patients which was associated with shorter hospital stay and cost effective for the suffering families. No adverse reactions were noted in this study with the use of intravenous acetaminophen.
机译:客观的;确定静脉注射乙酰氨基酚对腹腔切除术后术后疼痛的疗效。材料与方法;在这项研究中拍摄了共有114名正在进行腹部子宫切除术的女性。该研究于2018年6月至2019年5月,在Multan的Nishtar医院麻醉学系。结果;我们的研究包括接受腹部子宫切除术的114名女士,研究病例的平均年龄为54.13±6.89岁(患者最低年龄为39岁,较大年龄为68岁)。我们的研究案例中的大部分是92(80.7%)的奇偶校验超过3个以上和美国麻醉学会(ASA)得分等级:93年(81.6%)。六十一(53.1%)属于农村地区,而手术的平均持续时间为72.80±11.32分钟。在我们的研究病例中的平均BMI水平被指出,23.98±4.17kg / m 2和肥胖存在于34例(29.8%)我们的研究病例中,并且减少疼痛的疗效为73.7%。结论;我们的研究结果支持静脉注射乙酰氨基酚(IVA)用于接受腹部子宫切除术的患者疼痛管理。静脉注射乙酰氨基酚是术后腹腔切除术患者的疼痛管理是安全的,可靠的,可有效的,这与较短的住院住宿和对痛苦家庭的成本效益有关。在该研究中没有使用静脉注射乙酰氨基酚的研究中没有不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号